Syncron names a new CMO and EVPEMEA and promotes three internal leaders, strengthening its leadership team to bring decision-making closer to customers ... .
Food and Drug Administration (FDA) has granted the De Novo marketing authorization for Syncron-E™, its software that supports respiratory therapists' assessment of patient-ventilator asynchrony by detecting evidence of ineffective efforts.